2-Isocyanatosulfonylbenzoic acid esters and preparation thereof.
Abstract
2-Isocyanatosulfonylbenzoic acid esters of the general formula wherein R is selected from various hydrocarbyl and substituted hydrocarbyl groups;R2 is H, Cl, Br, F, C1-C3 alkyl, -NO2, -OCH3, -SCH3, CF3, SO2CH3, N(CH3)2, CN, or 4-N=C=O; andR3 is H, Cl, Br or CH3 with the proviso that when R is other than C3-C10 alkynyl, then R2 must be 4-NCO. are novel intermediates for the preparation of herbicidal ureas. The isocyanates may be prepared e.g. by reacting a corresponding 2-sulfamoylbenzoate ester of general formula wherein R2' is NH2 or R2 as defined above, with a hydrocarbyl isocyanate and phosgene in the presence of a catalytic amount of a tertiary amine base and an inert solvent.

Term
Term ended
Projected expiry passed 2 February 2001, 25.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
12 claims: 1 independent, 11 dependent
- 1A compound selected from:wherein R is C 1 -C 12 alkyl;C 3 -C 10 alkenyl;C 3 -C 10 alkynyl;C 2 -C 6 alkyl substituted with one to four substituents selected from 0-3 atoms of F, Cl, Br or 0-2 methoxy groups;C 3 -C 6 alkenyl substituted with 1-3 atoms of F, Cl or Br;C 5 -C 8 cycloalkyl;C 5 -C 8 cycloalkenyl;C 5 -C 8 cycloalkyl substituted with substituents selected from one to four methyl groups, methoxy, alkyl substituents of C 2 -C 4 , F, Cl or Br;C 4 -C 10 cycloalkylalkyl;C 4 -C 8 cycloalkylalkyl with 1-2 CH 3 ;-CH 2 CH 2 OR 7 ;CH 2 CH 2 CH 2 OR 7 or where R 7 is -CH 2 CH 3 , CH(CH 3 ) 2 , phenyl, -CH 2 CH 2 Cl, -CH 2 CCl 3 ;(̵CH 2 CH 2 O)̵ n , R 8 or where R 8 is CH 3 , -CH 2 CH 3 , -CH(CH 3 ) 2 , phenyl, -CH 2 CH 2 Cl or -CH 2 CCl 3 and n' is 2 or 3;R 2 is H, Cl, Br, F, C 1 -C 3 alkyl, -NO 2 , -OCH 3 , -SCH 3 , CF 3 , SO 2 CH 3 , N(CH 3 ) 2 , CN, or 4-N=C=O;and R 3 is H, Cl, Br or CH 3 with the proviso that when R is other than C 3 -C 10 alkynyl, then R 2 must be 4-NCO.
76 paragraphs in 2 sections, as filed
Background of the invention
U.S. Patent 3,484,466 teaches a process in which an aromatic sulfonamide is phosgenated in the presence of an inert solvent and a catalytic amount of a hydrocarbyl isocyanate to form the corresponding arylsulfonyl isocyanate. 4-Isocyanatosulfonylbenzoate ester is listed as a compound which can be prepared by this method.
In U.S. Patent 3,379,758 arylsulfonyl monoisocyanates and arylsulfonyl diisocyanates are produced by a process which comprises mixing in the range 0° to 175°C, phosgene and an arylsulfonylurea of the formula Ar(SO<sub>2</sub>NHCONHR)<sub>n</sub>, wherein n is one or two, R is alkyl of one to 8 carbon atoms, inclusive, and Ar is phenyl or phenylene, unsubstituted or substituted with one or two substituents selected from the class consisting of alkyl of one to 8 carbon atoms, inclusive, cycloalkyl of 3 to 8 carbon atoms, inclusive, phenyl, naphthyl, aralkyl of 7 to 10 carbon atoms, inclusive, alkoxy of one to 8 carbon atoms, inclusive, halogen, nitro, cyano, sulfo, amino, dialkylamino of 2 to 12 carbon atoms, inclusive, and alkoxycarbonyl of 2 to 8 carbon atoms, inclusive.
In U.S. Patent 3,371,114 there is taught a process of converting an aromatic sulfonamide to the corresponding aromatic sulfonyl isocyanates. Phosgenation of the sulfonamide in the presence of a catalytic quantity of a hydrocarbyl isocyanate gives the desired sulfonyl isocyanate.
Summary of the Invention
None of the above references teach the interme- , diates necessary to make an improved class of highly active herbicidal sulfonylureas taught in U.S. Serial No. 029,281. According to the instant invention, such an intermediate has been discovered. The intermediate has the general formula: <chemistry id="chem0001" num="0001"><img file="EP0034431A2_D0001.tif" /></chemistry>wherein R is C<sub>1</sub>-C<sub>12</sub> alkyl; C<sub>3</sub>-C<sub>10</sub> alkenyl; C<sub>3</sub>-C<sub>10</sub> alkynyl; C<sub>2</sub>-C<sub>6</sub> alkyl substituted with one to four substituents selected from 0-3 atoms of F, Cl, Br or <sub>0</sub>-2 methoxy groups, C<sub>3</sub>-C<sub>6</sub> alkenyl substituted with 1-3 atoms of F, Cl or Br; C<sub>5</sub>-C<sub>8</sub> cycloalkyl; C<sub>5</sub>-C<sub>8</sub> cycloalkenyl; C<sub>5</sub>-C<sub>8</sub> cycloalkyl substituted with substituents selected from one to four methyl groups, methoxy, alkyl substituents of C<sub>2</sub>-C<sub>4</sub>, F, Cl or Br; C<sub>4</sub>-C<sub>10</sub> cycloalkylalkyl; C<sub>4</sub>-C<sub>8</sub> cycloalkylalkyl with 1-2 CH<sub>3</sub>; -CH<sub>2</sub>CH<sub>2</sub>OR<sub>7</sub>; CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OR<sub>7</sub> or <chemistry id="chem0002" num="0002"><img file="EP0034431A2_D0002.tif" /></chemistry>where R<sub>7</sub> is -CH<sub>2</sub>CH<sub>3</sub>, CH(CH<sub>3</sub>)<sub>2</sub>, phenyl, -CH<sub>2</sub>CH<sub>2</sub>Cl, -CH<sub>2</sub>CCl<sub>3</sub>; (̵CH<sub>2</sub>CH<sub>2</sub>O)̵<sub>n</sub>,R<sub>8</sub> or <chemistry id="chem0003" num="0003"><img file="EP0034431A2_D0003.tif" /></chemistry>where R<sub>8</sub> is CH<sub>3</sub>, -CH<sub>2</sub>CH<sub>3</sub>, -CH(CH<sub>3</sub>)<sub>2'</sub> phenyl, -CH<sub>2</sub>CH<sub>2</sub>Cl or -CH<sub>2</sub>CC1<sub>3</sub> and n' is 2 or 3;, R<sub>2</sub> is H, Cl, Br, F, C<sub>1</sub>-C<sub>3</sub> alkyl, -NO<sub>2</sub>, -OCH<sub>3</sub>, -SCH<sub>3</sub>, CF<sub>3</sub>, SO<sub>2</sub>CH<sub>3</sub>, N(CH<sub>3</sub>)<sub>2</sub>CN; or 4-N=C=O; and R<sub>3</sub> is H, Cl, Br or CH<sub>3</sub>.
Preferred are the following:
<ul id="ul0001" list-style="none"><li>1) A compound of the generic scope where the carbon of R bonded to 0 is also bonded to at least one H.</li><li>2) A compound of preferred 1) where R<sub>3 </sub>is H and is para to the sulfonyl group.</li><li>3) A compound of preferred 2) where R is C<sub>1</sub>-C<sub>6 </sub>alkyl, C<sub>3</sub>-C<sub>6</sub> alkenyl; C<sub>2</sub>-C<sub>4</sub> alkyl substituted with one to four substituents selected from 0-3 F, Cl, 0-2 OCH<sub>3</sub>; C<sub>3</sub>-C<sub>4 </sub>alkenyl substituted with 1-3 Cl; C<sub>5</sub>-C<sub>6</sub> cycloalkyl; C<sub>5</sub>-C<sub>6</sub> cycloalkenyl; C<sub>5</sub>-C<sub>6 </sub>cycloalkyl substituted with up to four methyl groups, methoxy, C<sub>2</sub>H<sub>5</sub> or chloro; C<sub>4</sub>-C<sub>7</sub> cycloalkylalkyl; -CH<sub>2</sub>CH<sub>2</sub>OR<sub>7</sub>, <chemistry id="chem0004" num="0004"><img file="EP0034431A2_D0004.tif" /></chemistry>or -CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>OR<sub>7</sub> where R<sub>7</sub> is as previously defined; (̵CH<sub>2</sub>CH<sub>2</sub>O)̵<sub>2</sub>R<sub>8</sub> or <chemistry id="chem0005" num="0005"><img file="EP0034431A2_D0005.tif" /></chemistry>where R<sub>8</sub> is as previously defined.</li><li>4) Compounds of preferred 3) where R<sub>2 </sub>is H, Cl, CH<sub>3</sub>, NO<sub>2 </sub>or 4-N=C=O. More Preferred are:</li><li>5) Compounds of preferred 2) where R is C<sub>1</sub>-C<sub>4</sub> alkyl; C<sub>3</sub>-C<sub>4</sub> alkenyl; <sup>C</sup><sub>2</sub>-<sup>C</sup><sub>3</sub> alkyl substituted with -OCH<sub>3</sub> or Cl; C<sub>3</sub> alkenyl substituted with 1-3 Cl; C<sub>5</sub>-C<sub>6</sub> cycloalkyl; cyclohexenyl; cyclohexyl substituted with 1-3 -CH<sub>3</sub>; or -CH<sub>2</sub>CH<sub>2</sub>OR<sub>7</sub> where R<sub>7</sub> is -C<sub>2</sub>H<sub>5</sub>, -CH(CH<sub>3</sub>)<sub>2</sub>, phenyl, -CH<sub>2</sub>CH<sub>2</sub>Cl; or -CHCH<sub>2</sub>OC<sub>2</sub>H<sub>5</sub>. CH<sub>3</sub></li><li>6) Compounds of preferred 5) where R<sub>2 </sub>is as defined in preferred 4).</li><li>7) Compounds of preferred 5) where R<sub>2</sub> is <sub>H</sub>.</li><li>8) Compounds of preferred 2) where R is C<sub>1</sub>-C<sub>4</sub> elkyl, C<sub>3</sub>-C<sub>4</sub> alkenyl; C<sub>2</sub>-C<sub>3</sub> alkyl substituted with Cl; -CH<sub>2</sub>CH<sub>2</sub>O(̵CF<sub>3</sub> or C<sub>2</sub>H<sub>5</sub>), <chemistry id="chem0006" num="0006"><img file="EP0034431A2_D0006.tif" /></chemistry>C<sub>2</sub>H<sub>5</sub>)̵ or -CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O(C<sub>3</sub> or C<sub>2</sub>H<sub>5</sub>).</li><li>9) Compounds of preferred 8) where R<sub>2</sub> is as defined in preferred 4).</li><li>1C. Compounds of preferred 6) where R<sub>2</sub> is as defined in preferred 7).</li></ul>
The following species are particularly preferred. Methyl 2-(isocyanatosulfonyl)benzoate; Ethyl 2-(isocyanatosulfonyl)benzoate; (1-Methylethyl) 2-(isocyanatosulfonyl)benzoate; (2-Chloroethyl) 2-(isocyanatosulfonyl)benzoate; (2-Propenyl) 2-(isocyanatosulfonyl)benzoate; Methyl 2-(isocyanatosulfonyl)-4-nitrobenzoate; Methyl 4-chloro-2-(isocyanatosulfonyl)benzoate; (1-Methylethyl) 2-(isocyanatosulfonyl)-4-nitrobenzoate; and Methyl 4-isocyanato-2-(isocyanatosulfonyl)benzoate. Synthesis
Herbicidal compounds of Formula III are prepared as shown in Equation 1 by the reaction of an appropriately substituted o-isocyanatosulfonylbenzoate ester of this invention with an appropriate aminopyrimidine or aminotriazine. Thus, o-isocyanatosulfonylbenzoate esters are important intermediates for the preparation of these herbicides. The compounds of this invention wherein R is alkynyl may be used to make the corresponding herbicidal sulfonamides disclosed in European Patent Application 80304283.7.
Formula III
<chemistry id="chem0007" num="0007"><img file="EP0034431A2_D0007.tif" /></chemistry>wherein R, R<sub>2</sub> and R<sub>3</sub> are as described above and R<sub>1</sub> is <chemistry id="chem0008" num="0008"><img file="EP0034431A2_D0008.tif" /></chemistry>where X and Y are selected from OCH<sub>3</sub> or CH<sub>3</sub> and Z is <chemistry id="chem0009" num="0009"><img file="EP0034431A2_D0009.tif" /></chemistry><chemistry id="chem0010" num="0010"><img file="EP0034431A2_D0010.tif" /></chemistry>
A mixture of the appropriate sulfonamide, e.g. an o-sulfanoylbenzoate ester II such as the methyl ester, which is known in the art, a hydrocarbyl isocyanate such as butyl isocyanate and a catalytic amount of a tertiary amine base such as 1,4-diaza-[2,2,2]bicyclooctane (DABCO) in xylene or other inert solvent of sufficiently high boiling point (e.g. >135°) is heated to approximately 135°C. Phosgene is added to the mixture until an excess of phosgene is present as indicated by a drop in the boiling point. The mixture is then heated further to drive off the excess phosgene. After the mixture is cooled and filtered to remove a small amount of insoluble by-products, the solvent and alkyl isocyanate are distilled off in-vacuo leaving a residue which is the crude sulfonyl isocyanate I.
The hydrocarbyl isocyanates which are useful in the process are also described in the above-cited patent, U.S. 3,371,114. As disclosed therein, the only limitation on the nature of the hydrocarbyl moiety is that it should be free from substituents which are reactive with phosgene. Preferred in this invention for reasons of efficiency and economy are the C<sub>4</sub>-C<sub>10</sub> alkyl isocyanates and the C<sub>S</sub>-C<sub>S</sub> cycloalkyl isocyanates. For the purposes of this invention, a catalytic quantity of hydrocarbyl isocyanate will generally consist of an amount equal to about 0.2 to 1.0 mole of hydrocarbyl isocyanate per mole of arylsulfonamide.
The phosgenation reaction is carried out in the presence of a catalytic quantity of a tertiary amine base. Any tertiary amine base free of substituents reactive with phosgene may be used. Classes of tertiary amines which could be used include, but are not limited to, aliphatic, cycloaliphatic, aliphaticaromatic, heterocyclic and ali- phaticheterocyclic amines. Preferred for reasons of availability are those tertiary amines containing from three to ten carbon atoms and one to two nitrogen atoms. Examples of such bases are pyridine, triethylamine, 1,4-diazabicyclo[2,2,2]-octane, 4-dimethylaminopyridine, N,N-dimethylaniline, trimethylamine, N,N-diethylaniline, N-methylpiperidine, and N,N-dimethylpiperazine. Preferred for reasons of efficiency and economy are 1,4-diazabicyclo[2,2,2]-octane and triethylamine.
The tertiary amine base must be present in a catalytic quantity. This will generally be-in the range of about 0.2 to 5.0 grams of base per mole of arylsulfonamide.
The process of this invention is generally carried out within a temperature range of about 100-175°C although temperature is not critical. Pressure is also not critical, and atmospheric pressure is typically used.
The time required for the reaction to go to substantial completion may be readily monitored by techniques familiar to one skilled in the art, e.g., titration of the effluent hydrogen chloride gas or infrared analysis of the reaction mixture. Typically, the reaction time will be in th<sub>E</sub>. range of about 1 to 24 hours.
A suspension of the appropriate arylsulfonamide II in an inert solvent, a catalytic quantity of hydrocarbyl isocyanate and a catalytic quantity of a tertiary amine base are heated, with stirring, to reflux. The solvent can be any inert solvent with a boiling point within the range of about 100-200°C; examples of suitable solvents are xylene, chlorobenzene, mesitylene, toluene, pentachloroethane and octane. Phosgene is then introduced under a refrigerated reflux condenser at such a rate that the temperature of the reaction mass is maintained at about 5 to 8°C below the boiling point of the solvent. Following the phosgene addition, the reaction mixture is heated to drive off the small amount of excess phosgene, and is then cooled and filtered to remove small amounts of any by-product.
The filtered solution can be used directly to make compounds useful as herbicides. Alternatively, the product can be isolated by evaporation of the solvent and the hydrocarbyl isocyanate, leaving the high boiling arylsulfonyl isocyanate I as a residue. Generally, these arylsulfonyl isocyanates I can be distilled at reduced pressure or used without further purification.
In Equation 1
R, R<sub>2 </sub>and R<sub>3</sub> are as defined above.
Compounds of Formula I in which R<sub>2</sub> is isocyanato may be prepared according to Equation 2. <chemistry id="chem0011" num="0011"><img file="EP0034431A2_D0011.tif" /></chemistry>
A mixture of the appropriate ester of Formula V, two equivalents of an alkyl isocyanate such as butyl isocyanate and a catalytic amount of 1,4-diaza[2,2,2]-bicyclooctane (DABCO) in xylene or other inert solvent of sufficiently high boiling point (e.g. >135°C) is stirred at 0-10°C for 1-4 hours. The mixture is then heated to approximately 135°C and phosgene added until an excess of phosgene is present as indicated by a drop in the boiling point. (The mixture is heated further to drive off excess phosgene.) After the mixture is cooled and filtered to remove a small amount of insoluble by-products, the solvent and alkyl isocyanate are distilled off in-vacuo leaving residue which is the crude compound of Formula VI.
Alternatively, the method shown in Equation 3, may be used. A 2-sulfamoyl-4-nitrobenzoic acid ester is treated with butyl isocyanate at 80-135°C to form the sulfonylurea of Formula VII, followed by catalytic reduction of the nitro groups at 25-100°C and 50-200 psi of hydrogen pressure to the amino groups and subsequent treatment of the amino compound with phosgene at ~135°C to yield the 3-isocyanatobenzenesulfonylisocyanate (Formula VIII). <chemistry id="chem0012" num="0012"><img file="EP0034431A2_D0012.tif" /></chemistry>
Intermediates of Formula II are prepared, for example, by the procedures of B. Loev and M. Kormendy, J. Org. Chem. 27, 1703-1709, 2177-2180, 2448-2452 (1962), which are herein incorporated by reference.
As shown in Equation 2, compounds of Formula III, wherein R, R<sub>2 </sub>and R<sub>3</sub> are as defined for Equation 1, and R<sub>1 </sub>is as defined for Formula III, are conveniently prepared by reacting an appropriately substituted o-isocyanatosulfonylbenzoate ester of ' Formula I with an appropriately substituted aminopyrimidine or aminotriazine of Formula IV. <chemistry id="chem0013" num="0013"><img file="EP0034431A2_D0013.tif" /></chemistry>
The reaction of Equation 4 is best carried out in inert aprotic organic solvents such as methylene chloride, tetrahydrofuran or acetonitrile, at ambient pressure and temperature. The mode of addition is not critical; however, it is often convenient to add the sulfonyl isocyanate to a stirred suspensicn of amine IV. Since such isocyanates are liquids, low melting solids or are readily soluble in solvents such as those listed above, their addition can be easily controlled.
The reaction is generally exothermic. In some cases, the desired product is soluble in the warm reaction medium and on cooling crystallizes in pure form. Other products which are soluble in the reaction medium are isolated by evaporation of the solvent, trituration of the solid residue with solvents such as 1-chlorobutane or ethyl ether, and filtration.
In the following Examples, all temperatures are in °C and all parts are by weight unless otherwise indicated.
Example 1
Methyl 2-(isocyanatosulfonyl)benzoate
A stirred mixture containing 157 g of methyl 2-sulfamoylbenzoate, 73 g of butyl isocyanate 0.3 g of 1,4-diazabicyclo[2,2,2]octane and 1.0 ℓ of xylene was heated to reflux for one half hour. Phosgene gas was then passed into the system under a dry ice reflux condenser allowing the reaction temperature to drop to 120°. This addition was continued until the reflux temperature remained at 120° without further phosgene addition. The temperature of the reaction mixture was then raised to 136° (by removal of the dry ice reflux condenser) after which it was cooled to room temperature and filtered. Evaporation of the filtrate yielded the desired crude sulfonyl isocyanate which could be purified by distillation at 132-138°C under 1.0 to 1.1 mm of mercury pressure. The product is extremely reactive with water so contact with moisture should be scrupulously avoided.
Example 2
Isopropyl 2-(isocyanatosulfonyl)benzoate
To 60.7 g (.25 mole) of isopropyl 2-sulfamoylbenzoate in 300 ml dry (molecular sieves) xylenes was added 25.0 g (.25 mole) n-butyl isocyanate and .1 n-l,4-diazabicyclo[2,2,2]octane. The mixture was heated to reflux temperature and phosgene was slowly bubbled through the solution for 2 hours.
An infrared spectrum of the reaction mixture indicated formation of the desired sulfonyl isocyanate (2250 cm<sup>-1</sup>). The resulting cloudy solution was cooled to room temperature and decanted from a small amount of solid impurity. Evaporation of the resulting clear solution yielded the desired crude sulfonyl isocyanate, which was used in subsequent steps without further purification.
By using the procedures of Examples 1 and 2 or alternatively Equations 1-4 with equivalent amounts of the appropirate sulfamoylbenzoate, alkyl isocyanate, 1,4-diazabicyclo[2,2,2]octane and phosgene, the compounds of Table I can be prepared. Infrared absorption peaks listed in Table I for the isocyanate and o-carbonyl groups are given in reciprocal centimeters (cm<sup>-1</sup>). <tables id="tabl0001" num="0001"><img file="EP0034431A2_D0014.tif" /></tables><tables id="tabl0002" num="0002"><img file="EP0034431A2_D0015.tif" /></tables><tables id="tabl0003" num="0003"><img file="EP0034431A2_D0016.tif" /></tables><tables id="tabl0004" num="0004"><img file="EP0034431A2_D0017.tif" /></tables><tables id="tabl0005" num="0005"><img file="EP0034431A2_D0018.tif" /></tables>
Example 3
N-[(4,
6
-
D
imethylpyrimidin-2-yl)aminocarbonyl]-2-methoxycarbonvlbenzenesulfonamide
To 37 g of 2-amino-4,6-dimethylpyrimidine in ,500 ml of anhydrous acetonitrile was added 67 g of 2-methoxycarbonylbenzenesulfonyl isocyanate with stirring at ambient temperature. The resulting mixture was thereafter stirred for sixteen hours and then filtered to remove the desired product which had precipitated as a white solid, m.p. 198-202°.
It showed infrared absorption peaks at 1750, 1700, 1600 and 1550 cm<sup>-1</sup>, consistent for the desired compound.
Example 4
N-[(Pyrimidin-2-yl)aminocarbonyl]-2-methoxycarbonyl- benzenesulfonamide
With stirring at ambient temperature, 1.0 g of 2-aminopyrimidine in 25 ml of anhydrous acetonitrile was added to 2.4 g of 2-methoxycarbonylbenzenesulfonyl isocyanate. After stirring that mixture for 24 hours, the resultant precipitate was filtered off to yield 2.2 g of the desired compound which melted at 188-192°. Its showing infrared absorption peaks at 1700, 1680 and 1580 cm<sup>-1</sup> is consistent for N-[(pyrimidin-2-yl)aminocarbonyl]-2-methoxycarbonyl- benzenesulfonamide.
Example 5
N-[(4-Methoxy-6-methylpyrimidin-2-yl)aminocarbonyl]-2-methoxycarbonylbenzenesulfonamide
To a stirred suspension of 1.4 g of 2-amino-4-methoxy-6-methylpyrimidine in 30 ml of anhydrous methylene chloride was added at ambient temperature 2.4 g of 2-methoxycarbonylbenzenesulfonyl isocyanate. After stirring for 16 hours, the foregoing mixture was filtered to remove unreacted amine, and the filtrate evaporated at temperatures up to 40° and reduced pressure. The resultant residue was stirred in 25 ml of water, the pH adjusted to 10 by the addition of 50% sodium hydroxide and the solution filtered. Acidification of the filtrate to pH 3 with hydrochloric acid caused precipitation of the desired product which was removed by filtration and dried to yield 0.8 g of product melting at 173-179°. It showed infrared absorption peaks at 1720, 1680, 1630 and 1550 cm<sup>-1</sup>, consistent for N-[(4-methoxy-6-methylpyrimidin-2-yl)-aminocarbonyl]-2-methoxycarbonylbenzenesulfonamide.
Example 6
N-[(4,6-Dimethoxypyrimidin-2-yl)aminocarbonyl]-2-methoxycarbonylbenzenesulfonamide
A mixture containing 1.6 g of 2-amino-4,6-dimethoxypyrimidine, 30 ml of anhydrous methylene chloride and 2.4 g of 2-methoxycarbonylbenzenesulfonyl isocyanate was stirred at ambient temperature and pressure for 16 hours. It was then filtered to remove unreacted amine and the filtrate evaporated at temperatures up to 40° and reduced pressure. The residue thus obtained was stirred in 25 ml of water, the pH adjusted to 10 by the addition of 50% aqueous sodium hydroxide and the solution filtered. Acidification of the filtrate to pH 3 caused the formation of a precipitate. Filtration and drying the precipitate yielded 1.7 g of the desired product, melting at 185-190°. Its infrared absorption peaks at 1700 and 1710 cm<sup>-1</sup> are consistent for the desired structure and the nuclear magnetic resonance absorption peaks at 3.8 and 3.85 are consistent for the two different types of methoxy groups brought together in this product.
Example 7
N-[(4,6-Dimethoxy-1,3,5-triazin-2-yl)aminocarbonyl]-2-(2-chloroethoxycarbonyl)benzenesulfonamide
To .7 g of 2-amino-4,6-dimethoxy-l,3,5-triazine in 10 ml anhydrous methylene chloride solvent was added 1.45 g 2-(β-chloroethoxycarbonyl)benzenesulfonyl isocyanate. After stirring at ambient temperature for sixteen hours the solvent was removed under reduced pressure, the residue triturated with ether and the solid product filtered off, yield 1.21 g , m.p. 171-174°C. The solid showed infrared absorption peaks at 1705 and 1715 cm<sup>-1</sup>, consistent for N-[(4,6-dimethoxy-1,3,5-triazin-2-yl)aminocarbonyl]-2-(2-chloroethoxycarbonyl)benzenesulfonamide.
Example 8
N-[(4-Methoxy-6-methyl-1,3,5-triazin-2-yl)aminocarbonyl]-2-(2-chloroethoxycarbonyl)benzenesulfonamide
To .7 g of 2-amino-4-methoxy-6-methyl-l,3,5-triazine in 10 ml anhydrous methylene chloride solvent was added 1.45 g 2-(<sub>E</sub>-chloroethoxycarbonyl)benzenesulfonyl isocyanate with stirring at ambient temperature. The mixture was thereafter stirred for sixteen hours. The solvent was evaporated under reduced pressure and the residue triturated with hexane and filtered to yield 1.72 g of compound which melted at 167-170°C. The solid showed infrared absorption peaks at 1700 and 1705 cm<sup>-1</sup>, consistent for N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)aminocarbonyl]-2-(2-chloroethoxycarbonyl)benzenesulfonamide.
Example 9
N-[(4,6-Dimethoxy-1,3,5-triazin-2-yl)aminocarbonyl)]-2-(isopropoxycarbonyl)benzenesulfonamide
To .7 g of 2-amino-4,6-dimethoxy-1,3,5-triazine suspended in 5.0 ml anhydrous methylene chloride was added 1.6 g of 2-isopropoxycarbonylbenzenesulfonyl isocyanate in 5.0 ml of anhydrous methylene chloride. The resulting mixture was filtered to remove some unreacted 2-amino-4,6-dimethoxytriazine, the methylene chloride filtrate was evaporated at reduced pressure and the residue triturated with chlorobutane to yield .5 g of desired product melting at 192-195°C. The solid showed infrared absorption peaks at 1705 and 1715 cm<sup>-1</sup> consistent for N-[(4,6-dimethoxy-1,3,5-triazin-2-yl)aminocarbonyl]-2-(isopropoxycarbonyl)-benzenesulfonamide.
Example 10
N-[(4-Methoxy-6-methyl-1,3,5-triazin-2-yl)aminocar- boryl]-2-(isopropoxycarbonyl)benzenesulfonamide
To 26.8 g of 2-amino-4-methoxy-6-methyl-l,3,5-triazine in 300 ml anhydrous methylene chloride was added 67.0 a of 2-isopropoxycarbonylbenzenesulfonyl isocyanate in 100 ml anhydrous methylene chloride. The resultant suspension was stirred at ambient temperature for 72 hours, and filtered to yield 40.0 g of the desired product as a white solid, m.p. 193-196°C. The solid showed infrared absorption peaks at 1700 and 1710 cm<sup>-1</sup> consistent for N-[(4-methoxy-6-methyl-l,3,5-triazin-2-yl)aminocarbonyl]-2-(isopropoxycarbonyl)benzenesulfonamide.
Example 11
N-[(4,6-Dimethoxy-1,3,5-triazin-2-yl)aminocarbonyl]-2-methoxycarbonylbenzenesulfonamide
A mixture of 1.6 g of 2-amino-4,6-dimethoxy-l,3,5-triazine, 25 ml of anhydrous methylene chloride and 2.4 g of 2-methoxycarbonylbenzenesulfonyl isocyanate was stirred at ambient temperature for 16 hours. It was then filtered to remove unreacted amine and the filtrate evaporated at temperatures up to 40° under reduced pressure. The residue was triturated with butyl chloride and filtered to yield the desired compound which melted above 170° with decomposition.
Example 12
N
-[(4-Methoxy-6-methyl-1,3,5-triazin-2-yl)aminocarbonyl]-2-methoxycarbonylbenzenesulfonamide
To an anhydrous suspension of 1.4 g of 2-amino-4-methoxy-6-methyl-1,3,5-triazine in 25 ml of methylene chlcride was added with stirring at ambient temperature and pressure 2.4 g of 2-methoxycarbonylbenzenesulfonyl isocyanate. The mixture was thereafter stirred for 16 hours and filtered. The filtrate was evaporated tc dryness, the residue was triturated with butyl chloride and the product removed by filtration. The product thus obtained melted at 165°, and had absorption peaks in the infrared at 1550, 1600, 1680 and 1700 cm<sup>-1</sup> and in the NMR spectrum at 2.5, 3.65, 4.0 with an aromatic multiplet at 7.2-8 ppm.
The activity of compounds of Formula III can be seen in greenhouse and field tests. The tests are described and the data resulting from ther are shown below. The ratings are based on a numerical scale extending from 0 = no effect, to 10 = maximum effect. The accompanying descriptive symbols have the following meanings: <tables id="tabl0006" num="0006"><img file="EP0034431A2_D0019.tif" /></tables>
Test A
Seeds of crabgrass (Digitaria spp.), barnyardgrass (Echinochloa crusgalli), wild oats (Avena fatua), cassia (Cassia tora), morningglory (Ipomoea spp.), cocklebur (Xanthium spp.), sorghum, corn, soybean, rice, wheat and nutsedge tubers (Cyperus rotundus) were planted in a growth medium and treated preemergence with a nonphytotoxic solvent solution of the compounds of Table II. Other batches of seeds and tubers for all of the foregoing weed and crop plants were planted at the same time as controls.
The control plantings were untreated; i.e., neither any compound nor any solvent was applied. At the same time, cotton having five leaves (including cotyledonary ones), bush beans with the third trifoliate leaf expanding, crabgrass with two leaves, barnyardgrass with two leaves, wild oats with two leaves, cassia with three leaves (including cotyledonary ones), morningglory with four leaves (including the cotyledonary ones), cocklebur with four leaves (including the cotyledonary ones), sorghum with four leaves, corn with four leaves, soybean with two cotyledonary leaves, rice with three leaves, wheat with one leaf, and nutsedge with three- five leaves were sprayed with a nonphytotoxic solvent solution of the compounds of Table II. Other groups, of all the same weed and crop plants were sprayed with the same nonphytotoxic solvent so as to provide control plants. Preemergence and postemergence treated plants and controls were maintained in a greenhouse for sixteen days, then all treated plants were compared with their respective controls and rated visually for response to treatment. The data in Table II shows that the compounds of this invention are very effective as herbicides. <tables id="tabl0007" num="0007"><img file="EP0034431A2_D0020.tif" /></tables><tables id="tabl0008" num="0008"><img file="EP0034431A2_D0021.tif" /></tables><tables id="tabl0009" num="0009"><img file="EP0034431A2_D0022.tif" /></tables>
Contents2
33 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| CN1047166C | Cited by | China | Search report |
| US4659366A | Cited by | United States of America | Search report |
| WO9606826A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| EP0007687A1 | Cites | European Patent Office (EPO) | Search report |
| GB1359428A | Cites | United Kingdom | Search report |
| US3330848A | Cites | United States of America | Search report |
| US3379758A | Cites | United States of America | Search report |
| US3454606A | Cites | United States of America | Search report |
| US3484466A | Cites | United States of America | Search report |
97 members in 31 offices
Priority claims10
| Document | Office | Kind | Date |
|---|---|---|---|
| 119165 | United States of America | – | |
| 11916580 | United States of America | A | |
| 11916580 | United States of America | A | |
| 171355 | United States of America | – | |
| 17135580 | United States of America | A | |
| 17135580 | United States of America | A | |
| 119165 | – | – | – |
| 171355 | – | – | – |
| US19800119165 | – | – | – |
| US19800171355 | – | – | – |
Members97
| Document | Office | Kind | |
|---|---|---|---|
| PT69684A | Portugal | A | |
| IL57431D0 | Israel | D0 | |
| IE791064L | Ireland | L | |
| IE840703L | Ireland | L | |
| DK168679A | Denmark | A | |
| FI791711A | Finland | A | |
| NO791759L | Norway | L | |
| BR7903261A | Brazil | A | |
| AU4754579A | Australia | A | |
| JPS5513266A | Japan | A | |
| EP0007687A1 | European Patent Office (EPO) | A1 | |
| PL215949A1 | Poland | A1 | |
| ES481024A1 | Spain | A1 | |
| ZA792664B | South Africa | B | |
| US4238621A | United States of America | A | |
| AR221094A1 | Argentina | A1 | |
| IL62069D0 | Israel | D0 | |
| ES8105275A1 | Spain | A1 | |
| BR8007696A | Brazil | A | |
| EP0030138A1 | European Patent Office (EPO) | A1 | |
| JPS5690068A | Japan | A | |
| AU6684881A | Australia | A | |
| BR8100579A | Brazil | A | |
| EP0034431A2This record | European Patent Office (EPO) | A2 | |
| AU6479280A | Australia | A | |
| JPS56125356A | Japan | A | |
| US4305884A | United States of America | A | |
| GR68494B | Greece | B | |
| EP0046626A2 | European Patent Office (EPO) | A2 | |
| EP0034431A3 | European Patent Office (EPO) | A3 | |
| EP0046626A3 | European Patent Office (EPO) | A3 | |
| ZA806970B | South Africa | B | |
| CA1129857A | Canada | A | |
| ATA395979A | Austria | A | |
| EP0007687B1 | European Patent Office (EPO) | B1 | |
| NZ190589A | New Zealand | A | |
| NZ197926A | New Zealand | A | |
| BG33732A3 | Bulgaria | A3 | |
| DE2965095D1 | Germany | D1 | |
| TR21007A | Türkiye | A | |
| US4383113A | United States of America | A | |
| CA1150255A | Canada | A | |
| US4394506A | United States of America | A | |
| AU530575B2 | Australia | B2 | |
| AT371668B | Austria | B | |
| AU1328683A | Australia | A | |
| PL126541B1 | Poland | B1 | |
| IL68584D0 | Israel | D0 | |
| EG14339A | Egypt | A | |
| PL128153B1 | Poland | B1 | |
| AU534499B2 | Australia | B2 | |
| EP0046626B1 | European Patent Office (EPO) | B1 | |
| DE2966637D1 | Germany | D1 | |
| YU125179A | Yugoslavia, later Serbia and Montenegro (until 2006) | A | |
| EP0030138B1 | European Patent Office (EPO) | B1 | |
| AT7840T | Austria | T | |
| ATE7840T1 | Austria | T1 | |
| DE3068258D1 | Germany | D1 | |
| MX6387E | Mexico | E | |
| IL68584A | Israel | A | |
| IE49050B1 | Ireland | B1 | |
| IE49051B1 | Ireland | B1 | |
| FI68817B | Finland | B | |
| US4536576A | United States of America | A | |
| US4545808A | United States of America | A | |
| AU547325B2 | Australia | B2 | |
| FI68817C | Finland | C | |
| CA1199033A | Canada | A | |
| US4564384A | United States of America | A | |
| IL61579A | Israel | A | |
| US4591378A | United States of America | A | |
| HU188629B | Hungary | B | |
| US4592978A | United States of America | A | |
| US4627873A | United States of America | A | |
| US4647303A | United States of America | A | |
| US4687507A | United States of America | A | |
| US4689072A | United States of America | A | |
| US4721520A | United States of America | A | |
| US4755216A | United States of America | A | |
| NO158674B | Norway | B | |
| CS370879A2 | Czechoslovakia (until 1993) | A2 | |
| NO158674C | Norway | C | |
| CS261852B2 | Czechoslovakia (until 1993) | B2 | |
| US4818278A | United States of America | A | |
| US4830662A | United States of America | A | |
| US4892946A | United States of America | A | |
| YU44307B | Yugoslavia, later Serbia and Montenegro (until 2006) | B | |
| DK163123B | Denmark | B | |
| DK163123C | Denmark | C | |
| RU1836014C | Russian Federation | C | |
| LTIP463A | Lithuania | A | |
| LT3308B | Lithuania | B | |
| LV10894A | Latvia | A | |
| LV10894B | Latvia | B | |
| JP2552261B2 | Japan | B2 | |
| UA19873A | Ukraine | A | |
| NO1998019I1 | Norway | I1 |
7 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| Designated contracting statesAK | AK | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | |
| Designated contracting statesAK | AK | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 0034431
- Publication, DOCDB
- 0034431
- Publication, EPODOC
- EP0034431
- Application
- 81300429
- Application, DOCDB
- 81300429
- Application, EPODOC
- EP19810300429
Titles3
- German
- 2-Isocyanatsulfonylbenzoesäureester und ihre Herstellung
- English
- 2-Isocyanatosulfonylbenzoic acid esters and preparation thereof
- French
- Esters de l'acide 2-isocyanatosulfonyl-benzoique et leur préparation
Classification
- CPC, 3
- C07C311/65
- A01N47/36
- C07D521/00
- IPC, 2
- A01N47 36
- C07D521 00
Designated states1
- Contracting states, 1
- Sweden